INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAA6 Class: NOTE 3.250% 7/0

UBS ASSET MANAGEMENT AMERICAS INC's Holding History (CIK: 0000861177)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 200,000 Value ($000) $199 Avg Close — Range —
Q1 2023
Shares 200,000 Value ($000) $199 Avg Close — Range —
Q4 2022
Shares 200,000 Value ($000) $196 Avg Close — Range —
Q3 2022
Shares 200,000 Value ($000) $192,830 Avg Close — Range —
Q1 2022
Shares 322,000 Value ($000) $305,476 Avg Close — Range —
Q4 2021
Shares 322,000 Value ($000) $306,274 Avg Close — Range —
Q3 2021
Shares 522,000 Value ($000) $472,052 Avg Close — Range —
Q2 2021
Shares 35,000,000 Value ($000) $31,606,260 Avg Close — Range —
Q1 2021
Shares 35,000,000 Value ($000) $28,860,650 Avg Close — Range —
Q4 2020
Shares 35,000,000 Value ($000) $27,598,900 Avg Close — Range —
Q3 2020
Shares 32,000,000 Value ($000) $25,745,920 Avg Close — Range —
Q2 2020
Shares 50,000,000 Value ($000) $37,300,000 Avg Close — Range —
Q1 2020
Shares 52,500,000 Value ($000) $42,323,295 Avg Close — Range —
Q4 2019
Shares 32,000,000 Value ($000) $32,209,920 Avg Close — Range —
Q4 2016
Shares 12,500,000 Value ($000) $11,141 Avg Close — Range —
Q3 2016
Shares 40,500,000 Value ($000) $45,425 Avg Close — Range —